Influence of Weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance

Current Diabetes Reports

Volumn 4, Issue 3, 2004, Pages 165-168

  Kelley, David E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; INSULIN; LIPID;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MORBID OBESITY; MUSCLE LEVEL; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL ACTIVITY; REVIEW; WEIGHT REDUCTION;

EID: 3142514563     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-004-0018-4     Document Type: Review

References (44)

1. Pan DA, Lillioja S, Kriketos AD, et al.: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997, 46:983-988.
2. Phillips DW, Caddy S, Llic V, et al.: Intramuscular triglycerides and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 1996, 45:947-950.
3. Simoneau JA, Colberg SR, Thaete FL, Kelley DE: Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 1995, 9:273-278.
4. Goodpaster BH, Theriault R, Watkins SC, Kelley DE: Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 2000, 49:467-472.
5. He J, Watkins S, Kelley DE: Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001, 50:817-823.
6. Malenfant P, Joanisse D, Theriault R, et al.: Fat content in individual muscle fibers of lean and obese subjects. Int J Obes 2001, 25:1316-1321.
7. Wang N, Hikida R, Staron R, Simoneau J: Muscle fiber types of women after resistance training-quantitative ultrastructure and enzyme activity. Pflugers Arch 1993, 424:494-502.
8. Kelley DE, Slasky S, Janosky J: Skeletal muscle density: effects of obesity and non-insulin dependent diabetes mellitus. Am J Clin Nutr 1991, 54:509-515.
9. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE: Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997, 46:1579-1585.
10. Goodpaster BH, Thaete FL, Kelley DE: Thigh adipose tissue distribution is associated with insulin resistance and obesity in type 2 diabetes mellitus. Am J Clin Nutr 2000, 71:885-892.
11. Goodpaster BH, Kelley DE, Thaete FL, et al.: Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 2000, 89:104-110.
12. Goodpaster BH, Carlson CL, Visser M, et al.: Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol 2001, 90:2157-2165.
13. Boesch C, Slotboom J, Hoppeler H, Kreis R: In vivo determination of intramyocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 1997, 37:484-493.
14. Thamer C, Machann J, Bachmann O, et al.: Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 2003, 88:1785-1791.
15. Jacob S, Machann J, Rett K, et al.: Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 1999, 48:1113-1119.
16. Krssak M, Falk Petersen K, Dresner A, et al.: Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999, 42:113-115.
17. Perseghin G, Scifo P, DeCobelli F, et al.: Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic patients. Diabetes 1999, 48:1600-16066.
18. Petersen K, Befroy D, Dufour S, et al.: Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
19. Szcepaniak LS, Babcock EE, Schick F, et al.: Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999, 276:E977-E989.
20. Kim J, Kim Y, Fillmore J, et al.: Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001, 108:437-446.
21. Boden G, Lebed B, Schatz M, et al.: Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001, 50:1612-1017.
22. Itani S, Ruderman N, Schmieder F, Boden G: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002, 51:2005-2011.
23. Hoppeler H, Howald H, Conley K, et al.: Endurance training in humans: aerobic capacity and structure of skeletal muscle. J Appl Physiol 1985, 59:320-327.
24. Goodpaster B, He J, Watkins S, Kelley D: Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001, 86:5755-5761.
25. Romijn JA, Coyle EF, Sidossis LS, et al.: Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol 1993, 265:E380-E391.
26. Turcotte LP, Richter EA, Kiens B: Increased plasma FFA uptake and oxidation during prolonged exercise in trained versus untrained humans. Am J Physiol 1992, 262:E791-E799.
27. Simoneau JA, Kelley DE: Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 1997, 83:166-171.
28. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE: Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 1999, 13:2051-2060.
29. Kim J, Hickner R, Cortright R, et al.: Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 2000, 279:E1039-E1044.
30. Kelley DE, Simoneau JA: Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 1994, 94:2349-2356.
31. Kelley DE, Goodpaster BH, Wing RR, Simoneau JA: Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity and weight loss. Am J Physiol Endocrinol Metab 1999, 277:E1130-E1141.
32. Franssila-Kallunki A, Rissanen A, Ekstrand A, et al.: Weight loss by very-low-calorie diets: effects on substrate oxidation, energy expenditure, and insulin sensitivity in obese subjects. Am J Clin Nutr 1992, 56(suppl 1):247S-248S.
33. Goodpaster BH, Kelley DE, Wing RR, et al.: Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 1999, 48:839-847.
34. Niskanen L, Uusitupa M, Sarlund H, et al.: The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects. Int J Obes Relat Metab Disord 1996, 20:154-160.
35. Dengel D, Pratley R, Hagberg J, et al.: Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J Appl Physiol 1996, 81:318-325.
36. Ross R, Dagnone D, Jones P, et al.: Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000, 133:92-103.
37. Houmard J, Tanner C, Yu C, et al.: Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 2002, 51:2959-2963.
38. Greco A, Mingrone G, Giancaterini A, et al.: Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002, 51:144-151.
39. He J, Goodpaster BH, Kelley DE: Effects of weight loss and increased physical activity on intramyocellular lipid and lipid droplet size in obesity. Obes Res 2004, in press.
40. Goodpaster B, Katsiaris A, Kelley DE: Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 2003, 52:2191-2197.
41. Bruce C, Anderson M, Carey A, et al.: Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 2003, 88:5444-5451.
42. Helge J, Dela F: Effect of training on muscle triacylglycerol and structural lipids: a relation to insulin sensitivity? Diabetes 2003, 52:1881-1887.
43. Malenfant P, Tremblay A, Doucet E, et al.: Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training. Am J Physiol Endocrinol Metab 2001, 280:E632-E639.
44. Schrauwen-Hinderling V, Schrauwen P, Hesselink M, et al.: The increase in intramyocellular lipid content is a very early response to training. J Clin Endocrinol Metabol 2003, 88:1610-1616.